![](/img/cover-not-exists.png)
FRI0161 A Phase 1B/2A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of XMAB®5871 in Patients with Rheumatoid Arthritis
Jaraczewska-Baumann, M., Korkosz, M., Sulyok, G., Sramek, P., Rojkovich, B., Daniluk, S., Bartalos, J., Zack, D.J., Foster, P.Volume:
74
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2015-eular.2851
Date:
June, 2015
File:
PDF, 106 KB
english, 2015